Heidi Thompson, ScentsyHeidi Thompson, who previously served as president of Scentsy, will now share the title of co-CEO with Orville Thompson. The husband and wife team founded the company 15 years ago and have led Scentsy as equal partners, though unofficially. They have since scaled back their involvement in daily operations and will continue to focus on long-term, high-level contributions to company growth.
Dan Orchard, ScentsyDan Orchard has been promoted to president of Scentsy. He was previously general manager of emerging markets and has been an integral part of Scentsy’s executive team for 10 years, with strong engagement and interactions with consultants in multiple roles and leading international expansion. His prior direct selling experience includes working with Nu Skin.
Without warning, company restructures compensation plan to single-level; field leaders stunned
By Teresa Craighead
The sudden announcement has created speculation throughout the channel, with [experts] asking why a company with $472 million in revenue would choose to so dramatically change its business model, seemingly overnight.
“The FTC has basically told us what the right way to do business is. [FTC Associate Director] Lois Greisman has repeatedly said ‘look to the settlement’, ‘look to the MLM business guidance.’ This seems to be a pretty clear indicator they weren’t kidding around.”
—Al Bala, CEO Mannatech
By David Rauf
Mannatech and Reliv both report losses in fourth quarter.
Note: We listen in on the public company earnings calls and read the transcripts so you don’t have to. Check back each quarter for our review with insights and takeaways for your own business.
This report includes an update on the earnings calls from Mannatech and Reliv, both of which had revenue losses for the year-end quarter.
Please see the March and April issues for reports from the other public direct selling companies.
Mannatech Inc.The Flower Mound, Texas-based nutritional supplement maker Mannatech says it successfully launched several new products in 2018—including a global expansion of its signature product line—but reported flat sales figures for 2018. Revenue also decreased during Q4. And the company’s stock dropped by 11 percent to $17.04 in March after reporting earnings, but rebounded to $18.00 by the second week of April.